5 Key Takeaways

• 1

  A study of 13,905 patients with inflammatory arthritis found a higher risk of major adverse cardiovascular events in those with impaired fasting glucose.

• 2

  Patients with fasting glucose levels of 5.6 to 6.9 mmol/L were more than twice as likely to experience a cardiovascular event compared to those with normal levels.

• 3

  Diabetes medication type significantly affected cardiovascular risk, with sulfonylurea users having a 50% to 55% higher risk compared to nonusers.

• 4

  Insulin users faced over three times the risk of cardiovascular issues, while metformin users showed a lower unadjusted risk that was not statistically significant.

• 5

  The study highlighted the need for proactive glucose monitoring and careful selection of antidiabetic treatments in patients with inflammatory arthritis.